Kepos Capital’s Amedisys AMED Stock Holding History

Kepos Capital’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-23,091	Closed	-$2.8M	–	316
2019 Q2	$2.8M	Buy	+23,091	New	+$2.74M	0.28%	63

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Kepos Capital's AMED Position: Q3 2019 in Review

Kepos Capital sold out of Amedisys (AMED) in Q3 2019, closing a stake of 23,091 shares — an estimated $2.8M sold.

Kepos Capital first reported a position in AMED in Q2 2019 and held it in 1 quarter. The position peaked at $2.8M in Q2 2019. 283 funds tracked by Wall St. Rank hold AMED as of Q3 2019.

Kepos Capital reported no remaining Amedisys position as of Q3 2019 after selling out during the quarter.
Kepos Capital sold 23,091 Amedisys shares in Q3 2019, an estimated $2.8M.
Kepos Capital first reported a position in Amedisys in Q2 2019 and held it in 1 quarter.
Kepos Capital's Amedisys position peaked at $2.8M in Q2 2019.
283 funds tracked by Wall St. Rank held Amedisys as of Q3 2019.

Based on Kepos Capital's 13F filing for Q3 2019, filed 13 Nov 2019.